RegeneRx proposes follow-on

RegeneRx Biopharmaceuticals Inc. (NYSE-A:RGN) said late Friday that it plans to raise up to $12 million through the sale of units in a follow-on underwritten by Maxim Group and Boenning & Scattergood....